CATH Superfamily 4.10.40.20
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 1: Insulin-like growth factor binding protein 5
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 21 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
17 |
P08833 (/IPI)
P15473 (/IPI)
P17936 (/IPI)
P17936 (/IPI)
P22692 (/IPI)
P22692 (/IPI)
P22692 (/IPI)
P22692 (/IPI)
P22692 (/IPI)
P22692 (/IPI)
(7 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
11 |
P08833 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
(1 more) |
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
|
10 | A0A0B5JK49 (/IDA) A4IGH0 (/IDA) A4K8J2 (/IDA) B3F211 (/IDA) P08833 (/IDA) Q66I28 (/IDA) Q8JHX6 (/IDA) Q90YJ6 (/IDA) Q90YJ7 (/IDA) Q9PTH3 (/IDA) |
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
|
8 | A0A0B5JK49 (/IDA) A4IGH0 (/IDA) A4K8J2 (/IDA) P08833 (/IDA) Q66I28 (/IDA) Q8JHX6 (/IDA) Q90YJ6 (/IDA) Q90YJ7 (/IDA) |
Protein tyrosine phosphatase activator activity GO:0008160
Increases the activity of a phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a tyrosyl phenolic group of a protein.
|
6 | P15473 (/ISS) P16611 (/ISS) P16611 (/ISS) P20959 (/ISS) P20959 (/ISS) P47878 (/ISS) |
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
|
4 | P17936 (/IPI) P17936 (/IPI) P24593 (/IPI) P24593 (/IPI) |
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
|
4 | P47876 (/ISO) P47878 (/ISO) Q07079 (/ISO) Q07079 (/ISO) |
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
|
4 | A4IIA2 (/ISS) F1PEM7 (/ISS) P49705 (/ISS) Q5XHC5 (/ISS) |
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
|
4 | A4IIA2 (/ISS) B3F211 (/ISS) P49705 (/ISS) Q5XHC5 (/ISS) |
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
|
3 | P47878 (/IDA) Q07079 (/IDA) Q07079 (/IDA) |
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
|
3 | P47876 (/IPI) P47878 (/IPI) P47879 (/IPI) |
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
|
3 | P08833 (/TAS) P21743 (/TAS) P21744 (/TAS) |
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
|
2 | B3F211 (/IDA) P24594 (/IDA) |
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
|
2 | P17936 (/NAS) P17936 (/NAS) |
Protein tyrosine phosphatase activator activity GO:0008160
Increases the activity of a phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a tyrosyl phenolic group of a protein.
|
2 | P17936 (/IDA) P17936 (/IDA) |
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
|
2 | Q07079 (/TAS) Q07079 (/TAS) |
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
|
2 | P15473 (/IPI) Q9PTH3 (/IPI) |
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
|
2 | P47876 (/ISO) P47878 (/ISO) |
Metal ion binding GO:0046872
Interacting selectively and non-covalently with any metal ion.
|
2 | P17936 (/NAS) P17936 (/NAS) |
Protein tyrosine phosphatase activator activity GO:0008160
Increases the activity of a phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a tyrosyl phenolic group of a protein.
|
1 | P47878 (/ISO) |
There are 113 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
67 |
A0A024R433 (/ISS)
A0A024R433 (/ISS)
B3GS77 (/ISS)
D2GXE6 (/ISS)
D7PCU5 (/ISS)
E2I6L6 (/ISS)
F1PEQ5 (/ISS)
F6M3U6 (/ISS)
F6VH37 (/ISS)
F6YKJ0 (/ISS)
(57 more) |
Post-translational protein modification GO:0043687
The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
|
15 |
P08833 (/TAS)
P17936 (/TAS)
P17936 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
(5 more) |
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
|
15 |
P08833 (/TAS)
P17936 (/TAS)
P17936 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
(5 more) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
11 |
P08833 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
(1 more) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
11 |
P08833 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
(1 more) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
8 | C0LQH2 (/ISS) D6BJI0 (/ISS) F1PEM7 (/ISS) G9BWQ4 (/ISS) G9BWQ4 (/ISS) K9MMZ7 (/ISS) P16611 (/ISS) P16611 (/ISS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
6 | P15473 (/ISS) P16611 (/ISS) P16611 (/ISS) P20959 (/ISS) P20959 (/ISS) P47878 (/ISS) |
Positive regulation of myoblast differentiation GO:0045663
Any process that activates or increases the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
6 | P15473 (/ISS) P16611 (/ISS) P16611 (/ISS) P20959 (/ISS) P20959 (/ISS) P47878 (/ISS) |
Regulation of cell growth GO:0001558
Any process that modulates the frequency, rate, extent or direction of cell growth.
|
4 | P47878 (/IGI) P47879 (/IGI) Q07079 (/IGI) Q07079 (/IGI) |
Negative regulation of smooth muscle cell migration GO:0014912
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.
|
4 | P17936 (/IDA) P17936 (/IDA) P24593 (/IDA) P24593 (/IDA) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
4 | I6XXP7 (/IDA) I6XXP7 (/IDA) P20959 (/IDA) P20959 (/IDA) |
Regulation of growth GO:0040008
Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.
|
4 | P47878 (/IGI) P47879 (/IGI) Q07079 (/IGI) Q07079 (/IGI) |
Regulation of insulin-like growth factor receptor signaling pathway GO:0043567
Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
4 | A4IIA2 (/ISS) B3F211 (/ISS) P49705 (/ISS) Q5XHC5 (/ISS) |
Positive regulation of insulin-like growth factor receptor signaling pathway GO:0043568
Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
4 | P47878 (/IGI) P47879 (/IGI) Q07079 (/IGI) Q07079 (/IGI) |
Type B pancreatic cell proliferation GO:0044342
The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin.
|
4 | P47878 (/IGI) P47879 (/IGI) Q07079 (/IGI) Q07079 (/IGI) |
Negative regulation of smooth muscle cell proliferation GO:0048662
Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation.
|
4 | P17936 (/IDA) P17936 (/IDA) P24593 (/IDA) P24593 (/IDA) |
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
|
3 | P47878 (/IEP) Q07079 (/IEP) Q07079 (/IEP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
3 | A0A0B5JK49 (/IMP) Q8JHX6 (/IMP) Q90YJ7 (/IMP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
3 | P15473 (/IEP) P21743 (/IEP) P24594 (/IEP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
3 | A0A0B5JK49 (/IDA) Q8JHX6 (/IDA) Q90YJ7 (/IDA) |
Negative regulation of smooth muscle cell migration GO:0014912
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.
|
3 | P47878 (/ISO) Q07079 (/ISO) Q07079 (/ISO) |
Regeneration GO:0031099
The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).
|
3 | A0A0B5JK49 (/IMP) Q8JHX6 (/IMP) Q90YJ7 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
3 | P15473 (/IMP) P17936 (/IMP) P17936 (/IMP) |
Negative regulation of smooth muscle cell proliferation GO:0048662
Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation.
|
3 | P47878 (/ISO) Q07079 (/ISO) Q07079 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
2 | Q66I28 (/IMP) Q90YJ6 (/IMP) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
2 | P17936 (/IDA) P17936 (/IDA) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | P17936 (/IDA) P17936 (/IDA) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
2 | P24593 (/NAS) P24593 (/NAS) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
2 | Q90WV8 (/IMP) Q90WV8 (/IMP) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P17936 (/IGI) P17936 (/IGI) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P15473 (/IMP) Q9PTH3 (/IMP) |
Response to temperature stimulus GO:0009266
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
|
2 | M4Q8Z6 (/IDA) Q3HWG3 (/IDA) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
2 | Q90WV8 (/IMP) Q90WV8 (/IMP) |
Negative regulation of signal transduction GO:0009968
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.
|
2 | P17936 (/NAS) P17936 (/NAS) |
Regulation of glucose metabolic process GO:0010906
Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose.
|
2 | P47878 (/IGI) P47879 (/IGI) |
Negative regulation of translation GO:0017148
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
|
2 | P24593 (/IDA) P24593 (/IDA) |
Negative regulation of translation GO:0017148
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
2 | P24593 (/IDA) P24593 (/IDA) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|
2 | Q66I28 (/IDA) Q90YJ6 (/IDA) |
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|
2 | Q66I28 (/IGI) Q90YJ6 (/IGI) |
Otic vesicle formation GO:0030916
The process resulting in the transition of the otic placode into the otic vesicle, a transient embryonic structure formed during development of the vertebrate inner ear.
|
2 | Q66I28 (/IMP) Q90YJ6 (/IMP) |
Hair follicle morphogenesis GO:0031069
The process in which the anatomical structures of the hair follicle are generated and organized.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Inner ear morphogenesis GO:0042472
The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
|
2 | Q66I28 (/IMP) Q90YJ6 (/IMP) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
2 | Q07079 (/IGI) Q07079 (/IGI) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
2 | P17936 (/TAS) P17936 (/TAS) |
Positive regulation of MAPK cascade GO:0043410
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
|
2 | P47878 (/IGI) P47879 (/IGI) |
Regulation of insulin-like growth factor receptor signaling pathway GO:0043567
Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
2 | Q07079 (/TAS) Q07079 (/TAS) |
Negative regulation of insulin-like growth factor receptor signaling pathway GO:0043569
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
2 | P24593 (/IDA) P24593 (/IDA) |
Negative regulation of insulin-like growth factor receptor signaling pathway GO:0043569
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Negative regulation of insulin-like growth factor receptor signaling pathway GO:0043569
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Positive regulation of myoblast differentiation GO:0045663
Any process that activates or increases the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P17936 (/IDA) P17936 (/IDA) |
Negative regulation of osteoblast differentiation GO:0045668
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
|
2 | Q07079 (/IGI) Q07079 (/IGI) |
Negative regulation of growth GO:0045926
Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Insulin-like growth factor receptor signaling pathway GO:0048009
The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
|
2 | Q90WV8 (/IDA) Q90WV8 (/IDA) |
Insulin-like growth factor receptor signaling pathway GO:0048009
The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
|
2 | Q66I28 (/IEP) Q90YJ6 (/IEP) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Negative regulation of developmental growth GO:0048640
Any process that stops, prevents, or reduces the frequency, rate or extent of developmental growth.
|
2 | B3F211 (/IMP) Q9PTH3 (/IMP) |
Striated muscle cell differentiation GO:0051146
The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle.
|
2 | Q07079 (/IGI) Q07079 (/IGI) |
Striated muscle cell differentiation GO:0051146
The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
|
2 | Q66I28 (/IMP) Q90YJ6 (/IMP) |
Mammary gland involution GO:0060056
The tissue remodeling that removes differentiated mammary epithelia during weaning.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Cellular response to cAMP GO:0071320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
2 | P24593 (/IDA) P24593 (/IDA) |
Cellular response to cAMP GO:0071320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | P24593 (/IDA) P24593 (/IDA) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Negative regulation of muscle tissue development GO:1901862
Any process that stops, prevents or reduces the frequency, rate or extent of muscle tissue development.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Negative regulation of skeletal muscle hypertrophy GO:1904205
Any process that stops, prevents or reduces the frequency, rate or extent of skeletal muscle hypertrophy.
|
2 | Q07079 (/IMP) Q07079 (/IMP) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
2 | P24593 (/IGI) P24593 (/IGI) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Positive regulation of vascular associated smooth muscle cell migration GO:1904754
Any process that activates or increases the frequency, rate or extent of vascular associated smooth muscle cell migration.
|
2 | P24593 (/IGI) P24593 (/IGI) |
Positive regulation of vascular associated smooth muscle cell migration GO:1904754
Any process that activates or increases the frequency, rate or extent of vascular associated smooth muscle cell migration.
|
2 | Q07079 (/ISO) Q07079 (/ISO) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
1 | Q9PTH3 (/IMP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P15473 (/IEP) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
1 | P47878 (/ISO) |
Glucose metabolic process GO:0006006
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
|
1 | P21743 (/TAS) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
1 | P47878 (/ISO) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
1 | P21744 (/IEP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | Q9PTH3 (/IMP) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
1 | P15473 (/IEP) |
Negative regulation of DNA replication GO:0008156
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA replication.
|
1 | Q9PTH3 (/IMP) |
Negative regulation of DNA replication GO:0008156
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA replication.
|
1 | B3F211 (/ISS) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | P47878 (/ISO) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | B3F211 (/ISS) |
Insulin receptor signaling pathway GO:0008286
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
|
1 | P21743 (/IEP) |
Positive regulation of cardiac muscle cell apoptotic process GO:0010666
Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
|
1 | P15473 (/IMP) |
Positive regulation of cardiac muscle cell apoptotic process GO:0010666
Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
|
1 | P47878 (/ISO) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P21743 (/IEP) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P15473 (/IEP) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
1 | P15473 (/IEP) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
1 | P24594 (/IEP) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
1 | P21744 (/TAS) |
PERK-mediated unfolded protein response GO:0036499
A series of molecular signals mediated by the endoplasmic reticulum membrane stress sensor PERK (PKR-like ER kinase). Begins with activation of PERK in response to endoplasmic reticulum (ER) stress and ends with regulation of a downstream cellular process, e.g. transcription. The main substrate of PERK is the translation initiation factor eIF2alpha. Serine-phosphorylation of eIF2alpha by PERK inactivates eIF2alpha and inhibits general protein translation. In addition, eIF2alpha phosphorylation preferentially increases the translation of selective mRNAs such as ATF4 (activating transcription factor 4), which up regulates a subset of UPR genes required to restore folding capacity.
|
1 | P08833 (/TAS) |
Positive regulation of activated T cell proliferation GO:0042104
Any process that activates or increases the rate or extent of activated T cell proliferation.
|
1 | F1PEM7 (/ISS) |
Tissue regeneration GO:0042246
The regrowth of lost or destroyed tissues.
|
1 | P21743 (/IEP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P15473 (/IEP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | P47878 (/ISO) |
Regulation of insulin-like growth factor receptor signaling pathway GO:0043567
Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling.
|
1 | Q9PTH3 (/IMP) |
Positive regulation of myoblast differentiation GO:0045663
Any process that activates or increases the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
1 | P47878 (/ISO) |
Phosphatidylinositol-mediated signaling GO:0048015
A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
|
1 | P21743 (/TAS) |
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
1 | Q05717 (/IDA) |
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
1 | P15473 (/IEP) |
Response to caloric restriction GO:0061771
A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caloric restriction, insufficient food energy intake.
|
1 | P15473 (/IEP) |
Cellular response to estradiol stimulus GO:0071392
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
1 | P15473 (/IEP) |
Positive regulation of apoptotic DNA fragmentation GO:1902512
Any process that activates or increases the frequency, rate or extent of apoptotic DNA fragmentation.
|
1 | P15473 (/IMP) |
Positive regulation of apoptotic DNA fragmentation GO:1902512
Any process that activates or increases the frequency, rate or extent of apoptotic DNA fragmentation.
|
1 | P47878 (/ISO) |
Cellular response to Thyroglobulin triiodothyronine GO:1904017
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a Thyroglobulin triiodothyronine stimulus.
|
1 | P15473 (/IEP) |
Response to insulin-like growth factor stimulus GO:1990418
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
1 | P15473 (/IEP) |
Negative regulation of testosterone secretion GO:2000844
Any process that stops, prevents or reduces the frequency, rate or extent of testosterone secretion.
|
1 | P15473 (/IMP) |
Negative regulation of testosterone secretion GO:2000844
Any process that stops, prevents or reduces the frequency, rate or extent of testosterone secretion.
|
1 | P47878 (/ISO) |
There are 28 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
15 |
P08833 (/TAS)
P17936 (/TAS)
P17936 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
(5 more) |
Endoplasmic reticulum lumen GO:0005788
The volume enclosed by the membranes of the endoplasmic reticulum.
|
15 |
P08833 (/TAS)
P17936 (/TAS)
P17936 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
P22692 (/TAS)
(5 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
14 |
B3GS77 (/IDA)
I6XXP7 (/IDA)
I6XXP7 (/IDA)
M4Q8Z6 (/IDA)
P15473 (/IDA)
P17936 (/IDA)
P17936 (/IDA)
P20959 (/IDA)
P20959 (/IDA)
P21743 (/IDA)
(4 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
9 | C0LQH2 (/ISS) D6BJI0 (/ISS) F1P1I0 (/ISS) F1PEM7 (/ISS) G9BWQ4 (/ISS) G9BWQ4 (/ISS) K9MMZ7 (/ISS) P16611 (/ISS) P16611 (/ISS) |
Insulin-like growth factor binding protein complex GO:0016942
A complex of proteins which includes the insulin-like growth factor (IGF) and a number of IGF-binding proteins. The complex plays a role in growth and development.
|
6 | P17936 (/IC) P17936 (/IC) P24593 (/IC) P24593 (/IC) Q07079 (/IC) Q07079 (/IC) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
5 | A4IIA2 (/ISS) B3F211 (/ISS) P49705 (/ISS) Q5XHC5 (/ISS) Q9PTH3 (/ISS) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
5 | P15473 (/IDA) P17936 (/IDA) P17936 (/IDA) P24593 (/IDA) P24593 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
4 | P17936 (/NAS) P17936 (/NAS) P24593 (/NAS) P24593 (/NAS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
4 | P17936 (/IDA) P17936 (/IDA) Q66I28 (/IDA) Q90YJ6 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
3 | A0A0B5JK49 (/IDA) Q8JHX6 (/IDA) Q90YJ7 (/IDA) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
3 | C9J6H2 (/IDA) C9JXF9 (/IDA) P08833 (/IDA) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
3 | P47878 (/ISO) Q07079 (/ISO) Q07079 (/ISO) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
3 | P47878 (/ISS) Q07079 (/ISS) Q07079 (/ISS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | Q90WV8 (/IDA) Q90WV8 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P47878 (/HDA) P47879 (/HDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P47876 (/ISO) P47878 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | Q66I28 (/ISS) Q90YJ6 (/ISS) |
Insulin-like growth factor ternary complex GO:0042567
A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development.
|
2 | Q07079 (/TAS) Q07079 (/TAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | B3F211 (/IC) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P08833 (/TAS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | P47878 (/ISO) |
Nuclear heterochromatin GO:0005720
A condensed form of chromatin, occurring in the nucleus during interphase, that stains strongly with basophilic dyes. The DNA of heterochromatin is typically replicated at a later stage in the cell-division cycle than euchromatin.
|
1 | P15473 (/IDA) |
Nuclear heterochromatin GO:0005720
A condensed form of chromatin, occurring in the nucleus during interphase, that stains strongly with basophilic dyes. The DNA of heterochromatin is typically replicated at a later stage in the cell-division cycle than euchromatin.
|
1 | P47878 (/ISO) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | P47876 (/ISO) |
Platelet alpha granule GO:0031091
A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
|
1 | P15473 (/IDA) |
Platelet alpha granule GO:0031091
A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
|
1 | P47878 (/ISO) |
Insulin-like growth factor binary complex GO:0042568
A complex of two proteins, which in animals is 50kDa and consists of the insulin-like growth factor (IGF) and one of the insulin-like growth factor binding protein-1 (IGFBP-1), -2 (IGFBP-2), -4 (IGFBP-4) and -6 (IGFBP-6). The complex plays a role in growth and development.
|
1 | P15473 (/IDA) |
Insulin-like growth factor binary complex GO:0042568
A complex of two proteins, which in animals is 50kDa and consists of the insulin-like growth factor (IGF) and one of the insulin-like growth factor binding protein-1 (IGFBP-1), -2 (IGFBP-2), -4 (IGFBP-4) and -6 (IGFBP-6). The complex plays a role in growth and development.
|
1 | P47878 (/ISO) |